BrightSpring Health Services (NASDAQ:BTSG) Announces Earnings Results

BrightSpring Health Services (NASDAQ:BTSG) released its earnings results on Friday. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.07, FiscalAI reports. BrightSpring Health Services had a return on equity of 16.73% and a net margin of 2.55%. The business had revenue of $4.21 billion during the quarter, compared to the consensus estimate of $3.88 billion. The firm’s revenue for the quarter was up 26.4% on a year-over-year basis.

Here are the key takeaways from BrightSpring Health Services’ conference call:

• Strong third-quarter performance: Revenue rose 26% year over year to $4.2 billion, adjusted EBITDA increased 42% to $228 million, and adjusted EPS grew 80% to $0.54. Results exceeded the company’s forecast, supported by broad-based growth across Pharmacy Solutions and Provider Services.
• Specialty and infusion pharmacy revenue grew 34%, driven by 29% script growth, strong branded limited-distribution drug launches, generic contributions, pharma services, and mid-teens growth in acute and chronic infusion. BrightSpring launched seven additional LDDs during the quarter and now supports 162 total therapies.
• Provider Services revenue increased 31%, with home health census up approximately 58% and continued momentum in rehab and personal care. Management expects the acquired Amedisys and LHC branches to contribute approximately $35 million of adjusted EBITDA in 2026.
• BrightSpring raised or reaffirmed a strong outlook, projecting 2026 adjusted EBITDA of $850 million-$860 million and more than $700 million of operating cash flow, while reiterating expectations for at least 15%-20% organic adjusted EBITDA growth in 2027. Leverage declined to 1.79 times, including the impact of $120 million in year-to-date share repurchases.
• Home and community pharmacy revenue declined 6% year over year, primarily because of approximately $50 million of quarterly impact from the Inflation Reduction Act and exits from uneconomic customers. Management expects the IRA to remain a roughly $50 million headwind in the fourth quarter, although underlying growth and profitability are improving.

BrightSpring Health Services Stock Up 9.2%

NASDAQ BTSG traded up $5.54 on Friday, hitting $65.76. The stock had a trading volume of 3,848,451 shares, compared to its average volume of 2,844,723. The business’s fifty day moving average price is $59.79 and its 200 day moving average price is $54.40. The stock has a market cap of $13.01 billion, a price-to-earnings ratio of 39.62, a price-to-earnings-growth ratio of 0.77 and a beta of 1.87. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.59 and a quick ratio of 1.22. BrightSpring Health Services has a 52-week low of $30.64 and a 52-week high of $73.75.

Key BrightSpring Health Services News

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Quarterly earnings and revenue beat estimates. BrightSpring reported adjusted earnings of $0.54 per share, above consensus estimates ranging from $0.47 to $0.49 and up from $0.30 a year earlier. Revenue reached $4.21 billion versus the $3.88 billion consensus estimate. BrightSpring Q3 earnings and revenue results
• Positive Sentiment: Revenue growth remained strong. Sales increased 26.4% year over year, supporting the view that demand for BrightSpring’s home- and community-based healthcare services remains robust. BrightSpring Q3 revenue growth
• Positive Sentiment: Management raised full-year 2026 revenue and adjusted EBITDA guidance. The upgraded outlook is a significant bullish catalyst because it indicates that leadership expects the operating momentum to continue beyond the reported quarter. BrightSpring Q3 financial results and increased guidance
• Positive Sentiment: Profitability improved. The quarterly bottom line rose year over year, while reported net margin was 2.55% and return on equity was 16.73%, adding support to the positive earnings reaction. BrightSpring bottom-line growth
• Neutral Sentiment: The strong report follows a period in which investors questioned whether BrightSpring’s growth could offset ongoing risks tied to the Inflation Reduction Act and related healthcare reimbursement policies. Those issues remain important for future margins and guidance execution. BrightSpring earnings preview and IRA risks

Analyst Upgrades and Downgrades

A number of research firms have recently commented on BTSG. Raymond James Financial initiated coverage on shares of BrightSpring Health Services in a report on Thursday, July 9th. They issued an “outperform” rating and a $80.00 price target on the stock. Guggenheim assumed coverage on shares of BrightSpring Health Services in a report on Monday, July 13th. They set a “buy” rating and a $81.00 price objective for the company. BTIG Research reissued a “buy” rating and issued a $90.00 price objective on shares of BrightSpring Health Services in a research report on Thursday, August 13th. KeyCorp restated an “overweight” rating on shares of BrightSpring Health Services in a research note on Monday, August 3rd. Finally, UBS Group raised their target price on shares of BrightSpring Health Services from $63.00 to $85.00 and gave the stock a “buy” rating in a research report on Wednesday, July 8th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, BrightSpring Health Services currently has a consensus rating of “Moderate Buy” and a consensus target price of $72.88.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ:BTSG) is a Louisville, Kentucky-based provider of home- and community-based health services and pharmacy services. The company focuses on supporting individuals with complex or chronic care needs, including older adults and people with disabilities, through care delivered in homes, communities and other non-hospital settings.

Its services include home health, hospice, personal care, behavioral health, primary care, rehabilitation and community living programs.